Contents
Download PDF
pdf Download XML
246 Views
94 Downloads
Share this article
Research Article | Volume:1 Issue 3 (, 2011) | Pages 41 - 50
Effective Lipid-lowering Therapy in High-risk Patients
Under a Creative Commons license
Open Access
Published
Sept. 25, 2010
Abstract
Cardiovascular disease (CVD) is the primary cause of mortality in developed and developing societies. Identifying patients at high CVD risk is important but challenging. Measurement of classical risk factors is crucial for this assessment. Also, next to traditional factors such as lipids or lipoprotein levels, apolipoproteins or Lp(a) plasma levels may be important for such purposes. Moreover, the use of emerging biomarkers such as C-reactive protein is likely to gain importance in upcoming years in an attempt to better identify subgroups of patients that may be at increased cardiovascular risk. Our review will focus on novel tools that are, or will become available to identify patients at high CVD risk; and to discuss the potential usefulness of statins in these patients, with a particular focus on potent statin therapy.
Keywords
Recommended Articles
Research Article
Transport Risk Index of Physiologic Stability as a Predictor of Short-Term Outcomes in Critically Ill Transported Neonates: A Prospective Observational Study
...
Published: 30/09/2025
Download PDF
Research Article
Comparison of Conventional Epidural Block versus Dural Puncture Epidural Block on the Quality of Labour Analgesia
...
Published: 07/10/2025
Download PDF
Research Article
Pattern of Drug Use in ENT Patients: A Prospective Study
Published: 28/02/2017
Download PDF
Research Article
A Study to Assess the Effect of Planned Teaching on The Knowledge and Practices of Staff Nurses Regarding the Management of Intensive Care Unit Psychosis, In the Selected Hospitals of Mumbai
Published: 29/09/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.